Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention
NCT07649681
Blood Protein Disorders, Cardiovascular Diseases
Augsburg, Bavaria, Germany
View Trial DetailsNCT Number: NCT06929117
Gastrointestinal polyps (GIPs) are unusual growths of epithelial tissue projecting from the mucosa of gastrointestinal tract (GIT) and one of the most common pathologies affecting GIT . They are either proliferative or neoplastic mucosal lesions that are commonly seen in the colon and less commonly occur in the esophagus, stomach and small intestine. They may remain asymptomatic or present as bleeding, pain and obstruction due to mass effect. However, the most important risk with the gastrointestinal polyps is the development of malignancy in some of these polyps . Gastric polyps include hyperplastic, fundic gland polyps, inflammatory fibroid polyp, adenomas like pyloric gland adenoma, and oxyntic gland adenoma. Hyperplastic gastric polyps rarely undergo neoplastic progression (1.5-2.1%) but are associated with an increased risk of synchronous cancer occurring elsewhere in the gastric mucosa . Gastric adenomas are true neoplasms and precursors of gastric cancer. Adenomas larger than 20 mm in width and villous histology have a higher risk of neoplastic progression . The presence of gastric adenomas is strongly associated with synchronous or metachronous gastric adenocarcinoma . Polyps of the small bowel are rare compared to those of the colo-rectum, with adenomas being most common and having more preference for the distal duodenum, ampullary, and periampullary region Colonic Polyps may be classified according to their gross appearance (sessile or pedunculated), histopathological features (hyperplastic, adenoma, etc.), and behavior (benign or malignant). The biggest concern is their ability to progress into adenocarcinoma, through the adenoma to carcinoma sequence due to genetic mutation .
Trial opening soon.
Get NotifiedAll sexes
Observational
Gastrointestinal polyps (GIPs) are unusual growths of epithelial tissue projecting from the mucosa of gastrointestinal tract (GIT) and one of the most common pathologies affecting GIT . They are either proliferative or neoplastic mucosal lesions that are commonly seen in the colon and less commonly occur in the esophagus, stomach and small intestine. They may remain asymptomatic or present as bleeding, pain and obstruction due to mass effect. However, the most important risk with the gastrointestinal polyps is the development of malignancy in some of these polyps . Gastric polyps include hyperplastic, fundic gland polyps, inflammatory fibroid polyp, adenomas like pyloric gland adenoma, and oxyntic gland adenoma. Hyperplastic gastric polyps rarely undergo neoplastic progression (1.5-2.1%) but are associated with an increased risk of synchronous cancer occurring elsewhere in the gastric mucosa . Gastric adenomas are true neoplasms and precursors of gastric cancer. Adenomas larger than 20 mm in width and villous histology have a higher risk of neoplastic progression . The presence of gastric adenomas is strongly associated with synchronous or metachronous gastric adenocarcinoma . Polyps of the small bowel are rare compared to those of the colo-rectum, with adenomas being most common and having more preference for the distal duodenum, ampullary, and periampullary region Colonic Polyps may be classified according to their gross appearance (sessile or pedunculated), histopathological features (hyperplastic, adenoma, etc.), and behavior (benign or malignant). The biggest concern is their ability to progress into adenocarcinoma, through the adenoma to carcinoma sequence due to genetic mutation . With the use of Colonoscopy as an outpatient procedure to see inside of the colon and rectum and used in screening, diagnostic and therapeutic of rectal and colon diseases It is vital to discover high-risk polyps during colonoscopy to prevent colorectal cancer. This necessitates a more comprehensive description including morphology, anatomical distribution, and histopathology of those precursor lesions within the entire colon. Among patients with sporadic colorectal polyps, it is important to identify those at risk for malignancy. According to histopathology, serrated polyps, small distal hyperplastic polyps (HPs) have no substantial malignant potential and do not affect colonoscopic surveillance intervals. However, sessile serrated lesions (SSL) and traditional serrated adenomas (TSA) increase the risk of colorectal carcinoma. Generally, high-risk adenoma refers to patients with 1 or more of the following findings: 3 or more adenomas, adenoma ≥10 mm in size, and adenoma with tubulovillous/villous or high-grade dysplasia (HGD) histology . Neoplastic polyps are accountable for roughly 5-10% of population over age of 40 and these are important predisposing factor for majority of large bowel carcinoma cases. The neoplastic polyps are of primary importance because they harbor a malignant potential, which represents a stage in the development of colorectal cancer. For this reason, it is essential to identify these polyps at a sufficiently early stage, when a simple procedure to remove them can stop the development of colorectal cancer and prevent disease and death .
Non neoplastic polyps are important differential diagnosis for the neoplastic polyps and they include: Hyperplastic polyps, Hamartomatous polyps (juvenile polyps) and inflammatory polyps (pseudopolyps). The histopathological study is essential to detect dysplasia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients diagnosed with Gastrointestinal polyp based on standard clinical, endoscopic, and histological criteria will be included in the study.
-
Exclusion criteria
Time frame: during the period from January 2022 to December 2024
To assess the presence and grade of dysplasia either low grade or high grade dysplasia in all examined polyps.
Assiut University
Other
Acronym: Polyp
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07649681
Blood Protein Disorders, Cardiovascular Diseases
Augsburg, Bavaria, Germany
View Trial DetailsNCT07661017
Digestive System Diseases, Digestive System Neoplasms
View Trial DetailsNCT07605702
Colonic Diseases, Colorectal Cancer
San Diego, California, United States
View Trial DetailsNCT07054047
Colorectal Neoplasms, Digestive System Diseases
Southampton, Hampshire, United Kingdom
View Trial Details